Physician profile
Suzanne H Smith
NPI 1902917693
$1,381.01
in general payments reported to CMS, 2019-2025
18 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $871 · 2020: $191 · 2021: $67.66 · 2023: $21.24 · 2024: $111 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $330.85 | 2019-2025 | |
| Genentech USA, INC. | $225.53 | 2019-2020 | |
| Genzyme Corporation | $215.42 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $108.12 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $103.09 | 2019 | |
| Genentech, INC. | $76.00 | 2019 | |
| Alexion Pharmaceuticals, INC. | $62.90 | 2019-2024 | Soliris, Ultomiris |
| Celgene Corporation | $55.19 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $42.48 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $27.67 | 2019 | |
| Sk Life Science, INC. | $24.47 | 2024 | |
| Greenwich Biosciences, INC. | $22.53 | 2021 | |
| Amgen INC. | $21.04 | 2019 | |
| Abbvie INC. | $20.50 | 2024 | |
| Neurelis, INC. | $19.90 | 2024 | Valtoco |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $14.27 | 2025 | |
| Natus Medical Incorporated | $11.05 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.